Beyond Diagnostic Accuracy: Evaluating the Real-World Clinical Impact of AI-Enabled Radiology in Oncology and Nuclear Medicine
Oncology, Nuclear Medicine and Transplantology · 28.03.2026 · 2 (1) · onmt016
DOI: 10.63946/onmt/18258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, Nuclear Medicine and Transplantology, erschienen am 28.03.2026. Verfasst von Oluwafoyinsola Ayobami Obilaja und 4 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Artificial intelligence (AI) has become increasingly integrated into radiology and nuclear medicine, particularly in oncology, where imaging plays a central role in diagnosis, staging, treatment planning, and response assessment. To date, evaluation of AI-enabled radiology has been dominated by diagnostic accuracy metrics derived from retrospective validation studies. While such measures are essential for technical assessment, they provide limited insight into real-world clinical value. High algorithmic performance does not necessarily translate into improved decision-making, workflow efficiency, patient outcomes, or health system performance. This narrative review critically examines AI-enabled radiology as a digital health intervention in oncology and nuclear medicine, emphasizing the need to move beyond accuracy-centric evaluation paradigms. We analyze the translational gap between controlled validation and routine clinical deployment, highlighting challenges related to dataset bias, generalizability, and human–AI interaction. Key domains of real-world impact are explored, including clinical decision-making, multidisciplinary integration, workflow and operational performance, patient-centered outcomes, and system-level implications. Methodological considerations for outcome-focused evaluation are discussed, alongside regulatory, ethical, and governance frameworks necessary for responsible implementation. We propose a clinical-impact–centered evaluation framework that links AI-assisted imaging to patient, clinician, and system-level outcomes within a continuous monitoring model. Reframing AI-enabled radiology as a clinical intervention rather than a standalone algorithm is essential for ensuring meaningful, equitable, and sustainable adoption in oncology and nuclear medicine practice.
Zitieren
APA
Obilaja, O. A., Okeke, A. J., Nwosu-Ijiomah, C., Ayeyemi, B. M., & Mensah, A. (2026). Beyond Diagnostic Accuracy: Evaluating the Real-World Clinical Impact of AI-Enabled Radiology in Oncology and Nuclear Medicine. Oncology, Nuclear Medicine and Transplantology, 2(1), onmt016. https://doi.org/10.63946/onmt/18258
Vancouver
Obilaja OA, Okeke AJ, Nwosu-Ijiomah C, Ayeyemi BM, Mensah A. Beyond Diagnostic Accuracy: Evaluating the Real-World Clinical Impact of AI-Enabled Radiology in Oncology and Nuclear Medicine. Oncology, Nuclear Medicine and Transplantology. 2026;2(1):onmt016. doi:10.63946/onmt/18258
BibTeX
@article{Obilaja2026,
author = {Obilaja, Oluwafoyinsola Ayobami and Okeke, Amarachukwu Jessica and Nwosu-Ijiomah, Chinedu and Ayeyemi, Bolaji Mubarak and Mensah, Albert},
title = {Beyond Diagnostic Accuracy: Evaluating the Real-World Clinical Impact of AI-Enabled Radiology in Oncology and Nuclear Medicine},
journal = {Oncology, Nuclear Medicine and Transplantology},
year = {2026},
volume = {2},
number = {1},
pages = {onmt016},
doi = {10.63946/onmt/18258}
}
EUVIMED